89bio, Inc. (NASDAQ:ETNB – Get Free Report) was the target of a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 10,120,000 shares, a decrease of 5.9% from the April 30th total of 10,750,000 shares. Based on an average daily trading volume, of 1,050,000 shares, […]
Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report) was the target of a large drop in short interest in May. As of May 15th, there was short interest totalling 13,140,000 shares, a drop of 5.9% from the April 30th total of 13,970,000 shares. Currently, 47.2% of the shares of the stock are short sold. Based […]
Canaan Inc. (NASDAQ:CAN – Get Free Report) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 28,650,000 shares, an increase of 7.7% from the April 30th total of 26,590,000 shares. Based on an average daily volume of 13,290,000 shares, the short-interest ratio is […]
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report) insider Patrick Burnett sold 23,000 shares of the stock in a transaction that occurred on Thursday, May 30th. The stock was sold at an average price of $8.75, for a total value of $201,250.00. Following the sale, the insider now directly owns 209,793 shares of the company’s […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) CFO Cam Gallagher sold 9,597 shares of the business’s stock in a transaction dated Friday, May 31st. The shares were sold at an average price of $11.98, for a total value of $114,972.06. Following the sale, the chief financial officer now owns 633,680 shares in the company, […]